The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome

Critical Care Medicine

Volumn 27, Issue 2, 1999, Pages 304-312

  Pugin, Jérôme ^a   Verghese, George ^b   Widmer, Marie Claude ^a   Matthay, Michael A ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acute respiratory distress syndrome; Collagen; Fibrosis; Interleukin 8; Interleukin 1; Lung edema; Metalloproteinases; Proinflammatory cytokines

Indexed keywords

AUTACOID; BIOCHEMICAL MARKER; COLLAGENASE; GELATINASE A; GELATINASE B; INTERLEUKIN 8; METALLOPROTEINASE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLLAGEN SYNTHESIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; CYTOKINE PRODUCTION; ENZYME ACTIVATION; HUMAN; INFLAMMATORY INFILTRATE; LUNG ALVEOLUS; LUNG ALVEOLUS CELL; LUNG EDEMA; LUNG FIBROSIS; PATHOPHYSIOLOGY; PLASMA; PRIORITY JOURNAL; PROTEIN CONTENT; RANDOMIZED CONTROLLED TRIAL;

EID: 0032911805     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199902000-00036     Document Type: Article

References (53)

1. 1. Matthay MA: The adult respiratory distress syndrome. Definition and diagnosis. Clin Chest Med 1990; 11: 575-580
2. 2. Bernard GR, Artigas A, Brigham KL, et al: The American-European consensus conference on ARDS; definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149:818-824
3. 3. Koleff MH, Schuster DP: The acute respiratory distress syndrome. N Engl J Med 1995; 332:27-37
4. 4. Rinaldo JE, Christman JW: Mechanisms and mediators of the adult respiratory distress syndrome. Clin Chest Med 1990; 11:621-632
5. 5. Martin TR, Rubenfeld G, Steinberg KP, et al: Endotoxin, endotoxin-binding protein, and soluble CD14 are present in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Chest 1994; 105(Suppl):55S-56S
6. 6. Pugin J, Ricou B, Steinberg KP, et al: Proinflammatory activity in bronchoalveolar lavage fluid from patients with ARDS, a prominent role for interleukin-1. Am J Respir Crit Care Med 1996; 153:1850-1856
7. 7. Suter PM, Suter S, Girardin E, et al: High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am Rev Respir Dis 1992; 145:1016-1022
8. 8. Donnelly SC, Strieter RM, Kunkel SL, et al: Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet 1993; 341:643-647
9. 9. Millar AB, Singer M, Meager A, et al: Tumour necrosis factor in broncho-pulmonary secretions of patients with adult respiratory distress syndrome. Lancet 1989; ii:712-714
10. 10. Hyers TM, Tricomi SM, Dettenmeier PA, et al: Tumor necrosis factor levels in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1991; 144:268-271
11. 11. Miller EJ, Cohen AB, Nagao S, et al: Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis 1992; 146:427-432
12. 12. Meduri GU, Headley S, Kohler G, et al: Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1β and IL-6 levels are consistent and efficient predictors of outcome over time. Chest 1995; 107:1062-1073
13. 13. Martin TR, Pistonese BP, Hudson LD, et al: Function of lung and blood neutrophils in patients with the adult respiratory distress syndrome. Implications for the pathogenesis of lung infections. Am Rev Respir Dis 1991; 144:254-262
14. 14. Chollet-Martin S, Jourdain B, Gibert C, et al: Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS. Am J Respir Crit Care Med 1996; 153:594-601
15. 15. Ricou B, Nicod L, Lacraz S, et al: Matrix metalloproteinases and TIMP in acute respiratory distress syndrome. Am J Respir Crit Care Med 1996; 154:346-352
16. 16. Torii K, Iida K-I, Miyazaki Y, et al: Higher concentrations of matrix metalloproteinases in bronchoalveolar lavage fluid of patients with adult respiratory disctress syndrome. Am J Respir Crit Care Med 1997; 155:43-46
17. 17. Clark JG, Milberg JA, Steinberg KP, et al: Elevated lavage levels of N-terminal peptide of type III procollagen are associated with increased fatality in adult respiratory distress syndrome. Chest 1994; 105:126S-127S
18. 18. Clark JG, Milberg JA, Steinberg KP, et al: Type III procollagen peptide in the adult respiratory distress syndrome. Association of increased peptide levels in bronchoalveolar lavage fluid with increased risk for death. Ann Intern Med 1995; 122:17-23
19. 19. Le Gall JR, Lemeshow S, Saulnier F: A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270:2957-2963
20. 20. Murray JF, Matthay MA, Luce JM, et al: An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988; 138:720-723
21. 21. Matthay MA, Wiener-Kronish J: Intact epithelial barrier function is critical for the resolution of alveolar edema in humans. Am Rev Respir Dis 1990; 142:1250-1257
22. 22. Pugin J, Heumann D, Tomasz A, et al: CD14 is a pattern recognition receptor. Immunity 1994; 1:509-516
23. 23. Delclaux C, Delacourt C, d'Ortho M-P, et al: Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. Am J Respir Cell Mol Biol 1996; 14:288-295
24. 24. Kjeldsen L, Johnsen AH, Sengelov H, et al: Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 1993; 268:10425-10432
25. 25. Murawaki Y, Ikuta Y, Koda M, et al: Serum type III procollagen peptide, type IV collagen 7S domain, central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: relationship to liver histology. Hepatology 1994; 20:780-787
26. 26. Host NB, Jensen LT, Bendixen PM, et al: The aminoterminal propeptide of type III procollagen provides new information on prognosis after acute myocardial infarction. Am J Cardiol 1995; 76:869-873
27. 27. Kuroki S, Ohta A, Sueoka N, et al: Determination of various cytokines and type III procollagen aminopeptide levels in bronchoalveolar lavage fluid of the patients with pulmonary fibrosis: inverse correlation between type III procollagen aminopeptide and interferon-gamma in progressive patients. Br J Rheumatol 1995; 34:31-36
28. 28. Milman N, Kristensen MS, Bentsen K et al: Hyaluronan and procollagen type III aminoterminal peptide in serum and bronchoalveolar lavage fluid from patients with pulmonary fibrosis. APMIS 1995; 103:749-54
29. 29. Nielsen BS, Timshel S, Kjeldsen L, et al: 92 kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer. Int J Cancer 1996; 65:57-62
30. 30. Shapiro SD: Elastolytic metalloproteinases produced by human mononuclear phagocytes. Potential role in destructive lung disease. Am J Respir Crit Care Med 1994; 150:S160-S164
31. 31. Sengelov H, Follin P, Kjeldsen L, et al: Mobilization of granules and secretory vesicles during in vivo exudation of human neutrophils. J Immunol 1995; 154:4157-4165
32. 32. Krane SM: Clinical importance of metalloproteinases and their inhibitors. Ann N Y Acad Sci 1994; 732:1-10
33. 33. Jacobs RF, Tabor DR, Burks AW, et al: Elevated interleukin-1 release by human alveolar macrophages during the adult respiratory distress syndrome. Am Rev Respir Dis 1989; 140: 1686-1692
34. 34. Bone RC: Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: What we do and do not know about cytokine regulation. Crit Care Med 1996; 24:163-172
35. 35. Deitch EA: Cytokines yes, cytokines no, cytokines maybe? Crit Care Med 1993; 21:817-819
36. 36. Nicod L, Galve-de-Rochemonteix B, Dayer JM: Modulation of IL-1 receptor antagonist and TNF-soluble receptors produced by alveolar macrophages and blood monocytes. Ann NY Acad Sci 1994; 725:323-330
37. 37. Martin TR, Mathison JC, Tobias PS, et al: Lipopolysaccharide binding protein enhances the responsiveness of alveolar macrophages to bacterial lipopolysaccharide. Implications for cytokine production in normal and injured lungs. J Clin Invest 1992; 90:2209-2219
38. 38. Goodman RB, Strieter RM, Martin DP, et al: Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1996; 154:602-611
39. 39. Dentener MA, Bazil V, Von Asmuth EJ, et al: Involvement of CD14 in lipopolysaccharide-induced tumor necrosis factor-alpha, IL-6 and IL-8 release by human monocytes and alveolar macrophages. J Immunol 1993; 150: 2885-2891
40. 40. Pugin J, Schurer-Maly CC, Leturcq D, et al: Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci U S A 1993; 90: 2744-2748
41. 41. Standiford TJ, Kunkel SL, Basha MA, et al: Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung. J Clin Invest 1990; 86:1945-1953
42. 42. Miller EJ, Cohen AB, Matthay MA: Increased interleukin-8 concentrations in the pulmonary edema fluid of patients with acute respiratory distress syndrome from sepsis. Crit Care Med 1996; 24:1448-1454
43. 43. von Bethmann A, Brasch F, Müller KM, et al: Barotrauma induced cytokine-and eicosanoid-release from the isolated perfused and ventilated mouse lung. Abstr. Am J Respir Crit Care Med 1996; 153:A530
44. 44. Pardo A, Ridge K, Segura L, et al: Gelatinase A and intersticial collagenase are upregulated during high tidal volume mechanical ventilation. Abstr. Am J Respir Crit Care Med 1996; 153:A531
45. 45. Imai Y, Kawano T, Miyasaka K, et al: Inflammatory chemical mediators during conventional ventilation and during high frequency oscillatory ventilation. Am J Respir Crit Care Med 1994; 150:1550-1554
46. 46. Kawano T, Mori S, Cybulsky M, et al: Effect of granulocyte depletion in a ventilated surfactant-depleted lung. J Appl Physiol 1987; 62:27-33
47. 47. Cohen AB, Stevens MD, Miller EJ, et al: Neutrophil-activating peptide-2 in patients with pulmonary edema from congestive heart failure or ARDS. Am J Physiol 1993; 264:L490-L495
48. 48. Steinberg KP, Milberg JA, Martin TM, et al: Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome. Am J Respir Crit Care Med 1994; 150:113-122
49. 49. Yao PM, Buhler J-M, d'Ortho MP, et al: Expression of matrix metalloproteinase gelatinase A and B by cultured epithelial cells from human bronchial ex-plants. J Biol Chem 1996; 271: 15580-15589
50. 50. Meduri GU, Eltorky M, Winer-Muram HT: The fibroproliferative phase of late adult respiratory distress syndrome. Semin Respir Infect 1995; 10:154-175
51. 51. Martinet Y, Menard O, Vaillant P, et al: Cytokines in human lung fibrosis. Arch Toxicol Suppl 1996; 18:127-139
52. 52. Lindroos PM, Coin PG, Osornio-Vargas AR, et al: Interleukin-1β (IL-1β) and the IL-1β-alpha 2-macroglobulin complex upregulate the platelet-derived growth factor alpha on rat pulmonary fibroblasts. Am J Respir Cell Mol Biol 1995; 13:455-465
53. 53. Lonnemann G, Shapiro L, Engler-Blum G, et al: Cytokines in human renal intersticial fibrosis. Interleukin-1 is a paracrine growth factor for cultured fibrosis-derived kidney fibroblasts. Kidney Int 1995; 47:837-844